Vycor Medical (VYCO) Change in Accured Expenses (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Change in Accured Expenses of $11836.0 for Q1 2026, up 138.01% year-over-year from $4972.9 in Q1 2025, and down 2.17% quarter-over-quarter from $12099.0 in Q4 2025.
Vycor Medical (VYCO) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Change in Accured Expenses for 17 consecutive years, with $11836.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 138.01% year-over-year to $11836.0; the TTM figure through Mar 2026 stood at $90974.0 (up 144.04% YoY), while the FY2025 annual figure was $48000.0, changed 0.28% from the prior year.
- Change in Accured Expenses fell to $11836.0 in Q1 2026 per VYCO's latest filing, from $12099.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $104627.0 in Q3 2025 and bottomed at -$48693.0 in Q3 2022.
- Historically, Change in Accured Expenses has averaged $7080.1 across 5 years, with a median of $11836.0 in 2026.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses slumped 305.32% — and 2025, when it jumped 764.83%.
- Vycor Medical's Change in Accured Expenses stood at -$6093.0 in 2022, then soared by 395.49% to $18004.0 in 2023, then tumbled by 32.8% to $12099.0 in 2024, then changed by 0.0% to $12099.0 in 2025, then fell by 2.17% to $11836.0 in 2026.
- Business Quant data shows VYCO's Change in Accured Expenses at $11836.0 in Q1 2026, $12099.0 in Q4 2025, and $104627.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 11,967.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,836.00 |
| Mar 31, 2026 | 11,836.00 |
| Dec 31, 2025 | 12,099.00 |
| Dec 31, 2025 | 12,099.00 |
| Sep 30, 2025 | 104,627.00 |
| Sep 30, 2025 | 104,627.00 |
| Jun 30, 2025 | -37,588.00 |
| Jun 30, 2025 | -37,588.00 |
| Mar 31, 2025 | -31,138.00 |
| Mar 31, 2025 | -31,138.00 |
| Dec 31, 2024 | 12,099.00 |
| Dec 31, 2024 | 12,099.00 |
| Sep 30, 2024 | 12,098.00 |
| Sep 30, 2024 | 12,098.00 |
| Jun 30, 2024 | 44,220.00 |
| Jun 30, 2024 | 44,220.00 |
| Mar 31, 2024 | -20,284.00 |
| Mar 31, 2024 | -20,284.00 |
| Dec 31, 2023 | 18,004.00 |
| Dec 31, 2023 | 18,004.00 |